CD4 and neoplasm: The result demonstrated that anti-tumor lymphocyte cell subpopulations were enriched in the high-risk group, including activated CD4+ T cell, central memory CD4+ T cell, central memory CD8+ T cell, effector memory CD4 T cell, effector memory CD8 T cell, natural killer cell, natural killer T cell, and type 1 T helper cell.